Nuvation Bio Dividends and Buybacks

Dividend criteria checks 0/6

Nuvation Bio does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-0.7%

Buyback Yield

Total Shareholder Yield-0.7%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Nuvation Bio: Pending Approval Shot In ROSL+ NSCLS Looks A Major Upside Catalyst

Feb 13

Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way?

Nov 20
Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way?

Nuvation Bio: Competitive Data In ROS1+ NSCLC, Strong Cash, Smallish Market

Oct 21

Nuvation Bio: Continuing To Justify A Buy Thesis With Catalysts In 2024

Aug 08

Is Nuvation Bio (NYSE:NUVB) A Risky Investment?

Aug 07
Is Nuvation Bio (NYSE:NUVB) A Risky Investment?

Nuvation Bio: A Potentially Transformative Acquisition

Jun 20

Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate

Mar 31

Nuvation: Cash Is King, Science Is An Afterthought

Oct 03

We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth

Sep 14
We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth

Seth Klarman's Baupost adds Herbalife, Altice USA, exits Dropbox, Enhabit

Feb 14

We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely

Feb 10
We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely

We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth

Nov 09
We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth

Nuvation Bio GAAP EPS of -$0.12 beats by $0.02

Nov 03

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if NUVB's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NUVB's dividend payments have been increasing.


Dividend Yield vs Market

Nuvation Bio Dividend Yield vs Market
How does NUVB dividend yield compare to the market?
SegmentDividend Yield
Company (NUVB)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.6%
Industry Average (Pharmaceuticals)2.3%
Analyst forecast (NUVB) (up to 3 years)n/a

Notable Dividend: Unable to evaluate NUVB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NUVB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate NUVB's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as NUVB has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/10 04:51
End of Day Share Price 2025/03/07 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nuvation Bio Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Clarence PowellBMO Capital Markets Equity Research
Robert BurnsH.C. Wainwright & Co.
Michael YeeJefferies LLC